10-K Filing

AIM IMMUNOTECH INC. CIK: 946644 FY 2024

Filing Information

Form Type	10-K
Accession Number	`0001641172-25-000847`
Period End Date	20241231
Filing Date	20250327
Fiscal Year	2024
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 114 Income Statement 72 Cash Flow Statement 146 Stockholders Equity 34

Balance Sheet 114 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$2.28M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$2.28M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$7.63M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$7.63M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	$1.18M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	$1.18M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$302.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$302.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$199.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$199.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.56M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.56M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.53M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.53M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$108.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$108.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	49.10M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	49.10M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$127.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$127.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	49.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	49.10M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$618.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$618.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$697.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$697.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.53M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.59M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.59M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.31M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.31M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.11M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.11M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Total assets	`Assets`	$8.61M	USD	Point-in-time
Total assets	`Assets`	$8.61M	USD	Point-in-time
Total assets	`Assets`	$19.38M	USD	Point-in-time
Total assets	`Assets`	$19.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.44M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.44M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.38M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$606.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$606.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.99M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.99M	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$239.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$239.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$223.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$223.00K	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$2.31M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$2.31M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	-	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.65M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.65M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$495.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$495.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$395.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$395.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$9.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.15M	USD	Point-in-time
Commitments and contingencies (Notes 7, 8, 10, 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 7, 8, 10, 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 7, 8, 10, 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 7, 8, 10, 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 65,526,320 and 49,102,484 as of December 31, 2024 and 2023, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 65,526,320 and 49,102,484 as of December 31, 2024 and 2023, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 65,526,320 and 49,102,484 as of December 31, 2024 and 2023, respectively	`CommonStockValue`	$66.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 65,526,320 and 49,102,484 as of December 31, 2024 and 2023, respectively	`CommonStockValue`	$66.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$419.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$419.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$425.44M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$425.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-426.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-426.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-409.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-409.51M	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$38.47M	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$38.47M	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Total liabilities and stockholders (deficit) equity	`LiabilitiesAndStockholdersEquity`	$19.38M	USD	Point-in-time
Total liabilities and stockholders (deficit) equity	`LiabilitiesAndStockholdersEquity`	$19.38M	USD	Point-in-time
Total liabilities and stockholders (deficit) equity	`LiabilitiesAndStockholdersEquity`	$8.61M	USD	Point-in-time
Total liabilities and stockholders (deficit) equity	`LiabilitiesAndStockholdersEquity`	$8.61M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$202.00K	USD	Annual
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$202.00K	USD	Annual
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$170.00K	USD	Annual
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$170.00K	USD	Annual
Total Revenues	`Revenues`	$202.00K	USD	Annual
Total Revenues	`Revenues`	$202.00K	USD	Annual
Total Revenues	`Revenues`	$170.00K	USD	Annual
Total Revenues	`Revenues`	$170.00K	USD	Annual
Production costs	`ManufacturingCosts`	$31.00K	USD	Annual
Production costs	`ManufacturingCosts`	$31.00K	USD	Annual
Production costs	`ManufacturingCosts`	$42.00K	USD	Annual
Production costs	`ManufacturingCosts`	$42.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$10.94M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$10.94M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$6.20M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$6.20M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$13.71M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$13.71M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$21.14M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$21.14M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$32.12M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$32.12M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$19.94M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$19.94M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-31.92M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-31.92M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-19.77M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-19.77M	USD	Annual
(Loss) gain on investments	`GainLossOnInvestments`	$200.00K	USD	Annual
(Loss) gain on investments	`GainLossOnInvestments`	$200.00K	USD	Annual
(Loss) gain on investments	`GainLossOnInvestments`	$-93.00K	USD	Annual
(Loss) gain on investments	`GainLossOnInvestments`	$-93.00K	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$1.07M	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$1.07M	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$5.19M	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$5.19M	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Interest expense	`InterestExpense`	$585.00K	USD	Annual
Interest expense	`InterestExpense`	$585.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$18.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$18.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
(Loss) on warrant issuance	`GainLossOnWarrantIssuance`	-	USD	Annual
(Loss) on warrant issuance	`GainLossOnWarrantIssuance`	-	USD	Annual
(Loss) on warrant issuance	`GainLossOnWarrantIssuance`	$-458.00K	USD	Annual
(Loss) on warrant issuance	`GainLossOnWarrantIssuance`	$-458.00K	USD	Annual
(Loss) gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-1.67M	USD	Annual
(Loss) gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-1.67M	USD	Annual
(Loss) gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$1.60M	USD	Annual
(Loss) gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$1.60M	USD	Annual
Net Loss	`NetIncomeLoss`	$-28.96M	USD	Annual
Net Loss	`NetIncomeLoss`	$-28.96M	USD	Annual
Net Loss	`NetIncomeLoss`	$-17.32M	USD	Annual
Net Loss	`NetIncomeLoss`	$-17.32M	USD	Annual
Basic loss per share	`EarningsPerShareBasic`	$-0.60	USD	Annual
Basic loss per share	`EarningsPerShareBasic`	$-0.60	USD	Annual
Basic loss per share	`EarningsPerShareBasic`	$-0.31	USD	Annual
Basic loss per share	`EarningsPerShareBasic`	$-0.31	USD	Annual
Diluted loss per share	`EarningsPerShareDiluted`	$-0.31	USD	Annual
Diluted loss per share	`EarningsPerShareDiluted`	$-0.31	USD	Annual
Diluted loss per share	`EarningsPerShareDiluted`	$-0.60	USD	Annual
Diluted loss per share	`EarningsPerShareDiluted`	$-0.60	USD	Annual
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	48.59M	shares	Annual
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	48.59M	shares	Annual
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	56.02M	shares	Annual
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	56.02M	shares	Annual
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.59M	shares	Annual
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.59M	shares	Annual
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	56.02M	shares	Annual
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	56.02M	shares	Annual

Cash Flow Statement 146 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-28.96M	USD	Annual
Net loss	`NetIncomeLoss`	$-28.96M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.32M	USD	Annual
Depreciation of property and equipment	`Depreciation`	$39.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$39.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$37.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$37.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	$18.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	$18.00K	USD	Annual
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$14.00K	USD	Annual
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$14.00K	USD	Annual
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$48.00K	USD	Annual
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$48.00K	USD	Annual
Amortization of patent and trademark rights	`AmortizationOfIntangibleAssets`	$209.00K	USD	Annual
Amortization of patent and trademark rights	`AmortizationOfIntangibleAssets`	$209.00K	USD	Annual
Amortization of patent and trademark rights	`AmortizationOfIntangibleAssets`	$199.00K	USD	Annual
Amortization of patent and trademark rights	`AmortizationOfIntangibleAssets`	$199.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$287.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$287.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$304.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$304.00K	USD	Annual
Amortization of financial obligation	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of financial obligation	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of financial obligation	`AmortizationOfFinancingCosts`	$301.00K	USD	Annual
Amortization of financial obligation	`AmortizationOfFinancingCosts`	$301.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$686.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$686.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$243.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$243.00K	USD	Annual
Loss (gain) on sale of marketable securities	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$200.00K	USD	Annual
Loss (gain) on sale of marketable securities	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$200.00K	USD	Annual
Loss (gain) on sale of marketable securities	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$-93.00K	USD	Annual
Loss (gain) on sale of marketable securities	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$-93.00K	USD	Annual
Loss on fair value of warrants	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	Annual
Loss on fair value of warrants	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	Annual
Loss on fair value of warrants	`GainLossOnSaleOfDerivatives`	-	USD	Annual
Loss on fair value of warrants	`GainLossOnSaleOfDerivatives`	-	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInAccountsReceivable`	$-492.00K	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInAccountsReceivable`	$-492.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-103.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-103.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-153.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-153.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-274.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-274.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-309.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-309.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-576.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-576.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$486.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$486.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.07M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.07M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-60.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-60.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.20M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.20M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.18M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.18M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.27M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.27M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.89M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.89M	USD	Annual
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$1.30M	USD	Annual
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$1.30M	USD	Annual
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$5.62M	USD	Annual
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$5.62M	USD	Annual
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$1.59M	USD	Annual
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$1.59M	USD	Annual
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$361.00K	USD	Annual
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$361.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$47.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$47.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$538.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$538.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$585.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$585.00K	USD	Annual
Net cash provided by (used in) by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-832.00K	USD	Annual
Net cash provided by (used in) by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-832.00K	USD	Annual
Net cash provided by (used in) by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.71M	USD	Annual
Net cash provided by (used in) by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.71M	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$892.00K	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$892.00K	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$1.26M	USD	Point-in-time
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$1.26M	USD	Point-in-time
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$485.00K	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$485.00K	USD	Annual
Repayment of debt obligation	`RepaymentsOfDebtAndCapitalLeaseObligations`	-	USD	Annual
Repayment of debt obligation	`RepaymentsOfDebtAndCapitalLeaseObligations`	-	USD	Annual
Repayment of debt obligation	`RepaymentsOfDebtAndCapitalLeaseObligations`	$251.00K	USD	Annual
Repayment of debt obligation	`RepaymentsOfDebtAndCapitalLeaseObligations`	$251.00K	USD	Annual
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$2.50M	USD	Annual
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$2.50M	USD	Annual
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from issuance of equity warrants	`ProceedsFromIssuanceOfEquityWarrants`	$3.30M	USD	Annual
Proceeds from issuance of equity warrants	`ProceedsFromIssuanceOfEquityWarrants`	$3.30M	USD	Annual
Proceeds from issuance of equity warrants	`ProceedsFromIssuanceOfEquityWarrants`	-	USD	Annual
Proceeds from issuance of equity warrants	`ProceedsFromIssuanceOfEquityWarrants`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.44M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.44M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$485.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$485.00K	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.74M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.74M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-21.61M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-21.61M	USD	Annual
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Unrealized gain on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$570.00K	USD	Annual
Unrealized gain on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$570.00K	USD	Annual
Unrealized gain on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$376.00K	USD	Annual
Unrealized gain on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$376.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$689.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$689.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$7.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$7.00K	USD	Annual
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	-	USD	Annual
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	-	USD	Annual
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	$243.00K	USD	Annual
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	$243.00K	USD	Annual
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$73.00K	USD	Annual
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$73.00K	USD	Annual
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$31.00K	USD	Annual
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$31.00K	USD	Annual

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$485.00K	USD	Annual
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$485.00K	USD	Annual
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$892.00K	USD	Annual
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$892.00K	USD	Annual
Cashless exercise of warrants	`StockIssuedDuringPeriodValueCashlessExerciseOfWarrants`	-	USD	Annual
Cashless exercise of warrants	`StockIssuedDuringPeriodValueCashlessExerciseOfWarrants`	-	USD	Annual
Issuance of warrants	`StockIssuedDuringPeriodValueIssuanceOfWarrants`	$3.76M	USD	Annual
Issuance of warrants	`StockIssuedDuringPeriodValueIssuanceOfWarrants`	$3.76M	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueOther`	$243.00K	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueOther`	$243.00K	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueOther`	$686.00K	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueOther`	$686.00K	USD	Annual
Repayment of Debt with Shares	`StockIssuedDuringPeriodValueRepaymentOfDebt`	$425.00K	USD	Annual
Repayment of Debt with Shares	`StockIssuedDuringPeriodValueRepaymentOfDebt`	$425.00K	USD	Annual
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Net loss	`ComprehensiveIncomeNetOfTax`	$-28.96M	USD	Annual
Net loss	`ComprehensiveIncomeNetOfTax`	$-28.96M	USD	Annual
Net loss	`ComprehensiveIncomeNetOfTax`	$-17.32M	USD	Annual
Net loss	`ComprehensiveIncomeNetOfTax`	$-17.32M	USD	Annual
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.